Evaluating the Effectiveness of Incentive Spirometry

August 6, 2018 updated by: Adam Eltorai, Lifespan

Post-operative pulmonary complications (PPCs) have a major impact on patients and healthcare expenses. The goal of perioperative respiratory therapy is to improve airway clearance, increase lung volume, and mitigate atelectasis. Incentive spirometers (IS) are ubiquitously used to prevent atelectasis and PPCs-implementation of which requires substantial provider time and healthcare expenses. However, meta-analyses have demonstrated that the effectiveness of ISs is unclear due to poor patient compliance in past studies.

The goal of this investigation is evaluate the effectiveness of IS on post-operative clinical outcomes. The aims of this investigation are to evaluate 1) if IS use compliance can be improved by adding a use-recording patient reminder alarm, and 2) the clinical outcomes of the more compliant IS users vs. the less-compliant IS users.

Study Overview

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rhode Island
      • Providence, Rhode Island, United States
        • Rhode Island Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Undergoes any cardiothoracic surgery
  • Is transferred to the cardiothoracic surgery intermediate (step-down) unit at Rhode Island Hospital
  • Already prescribed an incentive spirometer as standard-of-care
  • Followed by any healthcare provider
  • Ability to sign informed consent and comply with all study procedures including follow-up for up to 1 year

Exclusion Criteria:

  • <18 years of age
  • Vulnerable population who in the judgment of the investigator is unable to give Informed Consent for reasons of incapacity, immaturity, adverse personal circumstances or lack of autonomy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Bell On
Subjects in the Bell On arm will receive a timer where the alarm will sound every hour.
Placebo Comparator: Bell Off
Subjects in the Bell Off arm will receive a timer where the alarm will not sound, but still record incentive spirometer usage

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compliance - Does the alarm improve IS use compliance?
Time Frame: up to 1 week postoperatively
The primary outcome will be to compare subjects' absolute IS usage count and hourly percent compliance in the Bell On arm vs the Bell Off arms.
up to 1 week postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Outcomes - Does IS use compliance improve clinical outcomes?
Time Frame: up to 1 week postoperatively
  • Subjective American Thoracic Society's Dyspnea Index43 - administered daily in ICTU

    • ICTU Day 1: Baseline Dyspnea Index
    • ICTU Day 2 through discharge: Transition Dyspnea Index
  • Objective Trend during ICTU stay

    • Vital signs (T, HR, RR, BP)
    • O2 saturation
    • Oxygen requirements
    • CBC Bedside Pulmonary Function Tests (Micro 1, Carefusion)
    • Daily FEV1, FVC, FEV6, PEF, FEV1/FVC, FEV1/FEV6 and F25-75 ratios. Wilcox atelectasis severity score44, 45
    • Scored 0-5 by daily chest x-ray
    • Collaboration with Dr. Terrance Healy, Chief of Chest Radiology, RIH Pneumonia
    • Rate of physician-diagnosed pneumonia
    • Pneumonia severity index48 Length of ICTU stay Mortality
    • In-hospital
    • 30 day post-discharge 30-day readmission rates
up to 1 week postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2016

Primary Completion (Actual)

January 1, 2018

Study Completion (Actual)

January 1, 2018

Study Registration Dates

First Submitted

October 18, 2016

First Submitted That Met QC Criteria

October 29, 2016

First Posted (Estimate)

November 2, 2016

Study Record Updates

Last Update Posted (Actual)

August 7, 2018

Last Update Submitted That Met QC Criteria

August 6, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pneumonia

Subscribe